Table 5. Data on serotonin.
GI - gastrointestinal, IBS - irritable bowel syndrome
| Study | Author/ reference no. | Year of publication | Type of study | Purpose of study | Results | Interpretation |
| The role of serotonin neurotransmission in gastrointestinal tract and pharmacotherapy molecules | Guzel et al. [7] | 2022 | Review | Identifying the role of serotonin in gut physiology and extrapolating its use to treat functional GI disorders. | Explain the role of serotonin in the gut-brain axis and IBS pathogenesis. Diarrhea-predominant IBS patients have high plasma serotonin levels and those with constipation-predominant IBS have low levels. | Serotonin agonists and antagonists and be used in IBS patients depending on their symptoms |
| Neurotransmitters: the critical modulators regulating gut-brain axis | Mittal et al. [6] | 2017 | Review | Illustrates the role of various neurotransmitters in gut physiology | Serotonin is a key regulator of gut immunity, motility, and inflammatory responses. | Serotonergic antagonists and agonists can be encouraged for the management of disorders of the gut-brain axis. |